Effect of oral caffeine on indirect bilirubin

Investigation of effect of oral caffeine on indirect bilirubin in term neonates

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20130812014333N238

Enrollment

164

Registered

2025-02-09

Start date

2025-02-18

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal jaundice. Neonatal jaundice, unspecified:Physiological jaundice (intense)(prolonged) NOS

Interventions

Intervention 1: The intervention group, in addition to the usual treatment for jaundice (for term infants, phototherapy including 4 to 8 lamps), takes caffeine medicine from Kimiyadaro Company orally

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Parental consent Infants with physiologic jaundice Term babies

Exclusion criteria

Exclusion criteria: Preterm infants Having pathological jaundice Being exposed to intensive phototherapy

Design outcomes

Primary

Measure	Time frame
Bilirubin. Timepoint: At the beginning of the study, daily for 4 days. Method of measurement: Using a blood sample.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Sareh Farshadfar

Kermanshah University of Medical Sciences

sareh111152@gmail.com+98 83 3724 6351

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026